Esperion Therapeutics ESPR Q1 2026 Disappoints EPS 010 Below 003 Views Option OPCH Q1 2026 Earnings Surprise EPS 040 Up Significant Portuguese Liqueur Brand Prevails in Trademark Battle Against Louis Vuitton Flat Market Day as Tech Gains Offset Energy Losses Iran Focus at TrumpXi Summit May Sideline Tariff and Rare Earths Progress Saratoga SAV Q1 2026 Results Miss Estimates EPS 016 vs 056 Birkenstock Warns of Rising Costs Amid Tariff Pressures and Middle East Tensions